55 related articles for article (PubMed ID: 2164065)
1. Restricted antibody diversity to major viral proteins of herpes simplex virus in individual syngeneic mice.
McKendall RR
J Immunol; 1990 Jul; 145(2):644-9. PubMed ID: 2164065
[TBL] [Abstract][Full Text] [Related]
2. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
4. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
[TBL] [Abstract][Full Text] [Related]
5. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies against herpes simplex viruses.
Scheffer AJ; Koedijk DG; Abee T; Osterhaus AD
Dev Biol Stand; 1984; 57():269-74. PubMed ID: 6098497
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
[TBL] [Abstract][Full Text] [Related]
8. Protective immunization of mice with specific HSV-1 glycoproteins.
Chan WL
Immunology; 1983 Jun; 49(2):343-52. PubMed ID: 6303950
[TBL] [Abstract][Full Text] [Related]
9. [Dynamics of the formation of antibodies to surface and internal proteins of the herpes simplex virus in a model experiment on rabbits].
Zvonarev AIu; Cheliapov NV; Ebralidze LK; Malytseva NN
Biull Eksp Biol Med; 1987 Oct; 104(10):476-8. PubMed ID: 2823927
[TBL] [Abstract][Full Text] [Related]
10. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins.
Ghiasi H; Bahri S; Nesburn AB; Wechsler SL
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1352-60. PubMed ID: 7775113
[TBL] [Abstract][Full Text] [Related]
11. Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.
Chan WL; Tizard ML; Faulkner L
Immunology; 1989 Sep; 68(1):96-101. PubMed ID: 2553584
[TBL] [Abstract][Full Text] [Related]
12. Immunoblotting analysis of class-specific antibody response in patients with primary HSV infection.
Lehtinen M; Koivisto V; Lehtinen T; Ylä-Outinen A; Romppanen U; Paavonen J
Acta Virol; 1989 Jan; 33(1):8-14. PubMed ID: 2565678
[TBL] [Abstract][Full Text] [Related]
13. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
[TBL] [Abstract][Full Text] [Related]
14. Humoral antibody response to individual viral proteins after murine cytomegalovirus infection.
Selgrade MK; Huang YS; Graham JA; Huang CH; Hu PC
J Immunol; 1983 Dec; 131(6):3032-5. PubMed ID: 6315823
[TBL] [Abstract][Full Text] [Related]
15. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
[TBL] [Abstract][Full Text] [Related]
16. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex virus type 1 in Igh-1-disparate congenic murine strains.
Hemady R; Tauber J; Ihley TM; Opremcak EM; Foster CS
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2335-41. PubMed ID: 2173686
[TBL] [Abstract][Full Text] [Related]
17. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
Novotny MJ; Parish ML; Spear PG
Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
[TBL] [Abstract][Full Text] [Related]
18. Differential recruitment of viral and allo-epitopes into the MHC class I antigen processing pathway of a novel mutant of Ltk- cells. HSV/MHC class I restriction/immune recognition/antigen processing/antigen presentation/influenza virus.
Lippé R; Kolaitis G; Michaelis C; Tufaro F; Jefferies WA
J Immunol; 1993 Apr; 150(8 Pt 1):3170-9. PubMed ID: 7682234
[TBL] [Abstract][Full Text] [Related]
19. The immunoglobulin response to individual HSV-1 viral polypeptides: kinetics of the response during primary and secondary experimental infection with herpes simplex virus.
McKendall RR; Pettit M; Woo W
J Med Microbiol; 1988 Jan; 25(1):59-66. PubMed ID: 2826790
[TBL] [Abstract][Full Text] [Related]
20. Enzyme immunoassay for detection of antibodies against herpes simplex virus with the use of different viral antigens.
Maltseva NN; Zvonarev AYu ; Matsevich GR; Ebralidze LK
Acta Virol; 1987 May; 31(3):226-33. PubMed ID: 2888286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
